Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis

Cancer Research

Volumn 60, Issue 3, 2000, Pages 722-727

  Pasqualini, Renata ^a,f   Koivunen, Erkki ^b   Kain, Renate ^c   Lahdenranta, Johanna ^a,f   Sakamoto, Michiie ^a,g   Stryhn, Anette ^d   Ashmun, Richard A ^e   Shapiro, Linda H ^e   Arap, Wadih ^a,f   Ruoslahti, Erkki ^a  

^a BURNHAM INSTITUTE   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE ANTIBODY; ANGIOGENESIS INHIBITOR; BESTATIN; DOXORUBICIN; MICROSOMAL AMINOPEPTIDASE; MICROSOMAL AMINOPEPTIDASE ANTAGONIST; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CHORIOALLANTOIS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TARGETING; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RECEPTOR BINDING;

AMINO ACID MOTIFS; ANGIOGENESIS INHIBITORS; ANIMALS; ANTIGENS, CD13; ANTINEOPLASTIC AGENTS; CHICKENS; HUMANS; MICE; NEOVASCULARIZATION, PATHOLOGIC; OLIGOPEPTIDES; PROTEASE INHIBITORS; TUMOR CELLS, CULTURED;

EID: 0033950895     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., 1: 27-31, 1995.
2. Hanahan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86: 353-364, 1996.
3. Risau, W., and Flamme, I. Vasculogenesis. Annu. Rev. Cell Dev. Biol., 11: 73-91, 1995.
4. v integrins. Science (Washington DC), 270: 1500-1502, 1995.
5. Hammes, H. P., Brownlee, M., Jonczyk, A., Sutter, A., and Preissner, K. T. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nat. Med., 2: 529-533, 1996.
6. Korpelainen, E. I., and Alitalo, K. Signaling angiogenesis and lymphangiogenesis. Curr. Opin. Cell Biol., 10: 159-164, 1998.
7. Lappi, D. A. Tumor targeting through fibroblast growth factor receptors. Semin. Cancer Biol., 6: 279-288, 1995.
8. Hass, T. L., Davis, S. J., and Madri, J. A. Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteases MT1-MMP and MMP-2 in microvascular endothelial cells. J. Biol. Chem., 273: 3604-3610, 1998.
9. Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M., and Werb, Z. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell, 93: 411-422, 1998.
10. Schlingemann, R. O., Rietveld, F. J., de Waal, R. M., Ferrone, S., and Ruiter, D. J. Expression of the high molecular weight melanoma-associated antigen by pericytes during angiogenesis in tumors and in healing wounds. Am. J. Pathol., 136: 1393-1405, 1990.
11. Burg, M. A., Pasqualini, R., Arap, W., Ruoslahti, E., and Stallcup, W. B. NG2 proteoglycan-binding peptides target tumor neovasculature. Cancer Res., 59: 2869-2874, 1999.
12. Arap, W., Pasqualini, R., and Ruoslahti, E. Chemotherapy targeted to tumor vasculature. Curr. Opin. Oncol., 10: 560-565, 1998.
13. Ferrara, N. Vascular endothelial growth factor: molecular and biological aspects. Curr. Top. Microbiol. Immunol., 237: 1-30, 1999.
14. Brooks, P. C., Clark, R. A., and Cheresh, D. A. Requirement of vascular integrin αvβ3 for angiogenesis. Science (Washington DC), 264: 569-571, 1994.
15. Arap, W., Pasqualini, R., and Ruoslahti, E. Cancer treatment by targeted drug delivery to tumor vasculature. Science (Washington DC), 279: 377-380, 1998.
16. Ellerby, E., Arap, W., Kain, R. Andrusiak, R., Ellerby, L., Del Rio, G., Krajewski, S., Lombardo, C. R., Ruoslahti, E., Bredesen, D. E., and Pasqualini, R. Anti-cancer activity of targeted pro-apoptotic peptides. Nat. Med., 5: 1032-1038, 1999.
17. Ruoslahti, E. RGD and other recognition sequences for integrins. Annu. Rev. Cell Dev. Biol., 12: 697-715, 1996.
18. Koivunen, E., Wang, B., and Ruoslahti, E. Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins. Bio/ Technology, 13: 265-270, 1995.
19. Pasqualini, R., Koivunen, E., and Ruoslahti, E. αv integrins as receptors for tumor targeting by circulating ligands. Nat. Biotechnol., 15: 542-546, 1997.
20. Healy, J. M., Murayama, O., Maeda, T., Yoshino, K., Sekiguchi, K., and Kikuchi, M. Peptide ligands for integrin αvβ3 selected from random phage display libraries. Biochemistry, 34: 3948-3955, 1995.
21. Shipp, M. A., and Look, A. T. Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key! Blood, 82: 1052-1070, 1993.
22. Look, A. T., Ashmun, R. A., Shapiro, L. H., and Peiper, S. C. Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J. Clin. Investig., 83: 1299-1307, 1989.
23. Olsen, J., Kokholm, K., Noren, O., and Sjostrom, H. Structure and expression of aminopeptidase N. Adv. Exp. Med. Biol., 421: 47-57, 1997.
24. Lendeckel, U. Arndt, M., Wex, T., and Ansorge, S. Role of alanyl aminopeptidase in growth and function of human T cells. Int. J. Mol. Med., 4: 17-27, 1999.
25. Saiki, I., Fujii, H., Yoneda, J., Abe, F., Nakajima, M., Tsuruo, T., and Azuma, I. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int. J. Cancer, 54: 137-143, 1993.
26. Fujii, H., Nakajima, M., Saiki, I., Yoneda, J., Azuma, I., and Tsuruo, T. Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13. Clin. Exp. Metastasis, 13: 337-344, 1995.
27. Stryhn, A., Norén, O., Sjöstrom, H., and Werdelin, O. A mouse aminopeplidase N is a marker for antigen-presenting cells and appears to be co-expressed with major histocompatibility complex class II molecules. Eur. J. Immunol., 23: 2358-2364, 1993.
28. Schlingemann, R. O., Oosterwijk, E., Wesseling, P., Rietveld, F. J., and Ruiter, D. J. Aminopeptidase A is a constituent of activated pericyles in angiogenesis. J. Pathol., 179: 436-442, 1996.
29. Ashmun, R. A., and Look, A. T. Metalloprotease activity of CD13/aminopeptidase N on the surface of human myeloid cells. Blood, 75: 462-469, 1990.
30. Smith, G. P., and Scott, J. K. Libraries of peptides and proteins displayed in filamentous phage. Methods Enzymol., 217: 228-257, 1993.
31. Pasqualini, R., Koivunen, E., and Ruoslahti, E. A peptide isolated from phage display libraries is a structural and functional mimic of an RGD-binding site on integrins. J. Cell Biol., 130: 1189-1196, 1995.
32. Rajotte, D., Arap, W., Hagedorn, M., Koivunen, E., Pasqualini, R., and Ruoslahti, E. Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J. Clin. Investig., 102: 430-437, 1998.
33. Smith, L. E., Wesolowski, E., McLellan, A., Kostyk, S. K., D'Amato, R., Sullivan, R., and D'Amore, P. A. Oxygen-induced retinopathy in the mouse. Investig. Ophthalmol. Vis. Sci., 35: 101-111, 1994.
34. Jain, R. K., Schlenger, K., Hockel, M., and Yuan, F. Quantitative angiogenesis assays: progress and problems. Nat. Med., 3: 1203-1208, 1997.
35. Klauber, N., Rohan, R. M., Flynn, E., and D'Amato, R. J. Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470. Nat. Med., 3: 443-446, 1997.
36. van Hal, P. T., Hopstaken-Broos, J. P., Prins, A., Favaloro, E. J., Huijbens, R. J., Hilvering, C., Figdor, C. G., and Hoogsteden, H. C. Potential indirect anti-inflammatory effects of IL-4. Stimulation of human monocytes, macrophages, and endothelial cells by IL-4 increases aminopeptidase-N activity (CD13; EC 3.4.11.2). J. Immunol., 153: 2718-2728, 1994.
37. Kunz, J., Krause, D., Kremer, M., and Dermietzel, R. The 140-kDa protein of blood-brain barrier-associated pericytes is identical to aminopeptidase N. J. Neurochem., 62: 2375-2386, 1994.
38. Zetter, B. R. Angiogenesis and tumor metastasis. Annu. Rev. Med., 49: 407-424, 1998.
39. Bussolino, F., Mantovani, A., and Persico, G. Molecular mechanisms of blood vessel formation. Trends Biochem. Sci., 22: 251-256, 1997.
40. Taylor, A. Aminopeptidases: structure and function. FASEB J., 7: 290-298, 1993.
41. Ward, P. E., Benter, I. F., Dick, L., and Wilk, S. Metabolism of vasoactive peptides by plasma and purified renal aminopeptidase N. J. Biol. Chem., 264: 5480-5487, 1990.